These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14672612)

  • 1. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis.
    Mezey E; Potter JJ; Rennie-Tankersley L; Caballeria J; Pares A
    J Hepatol; 2004 Jan; 40(1):40-6. PubMed ID: 14672612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
    Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
    J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.
    Carithers RL; Herlong HF; Diehl AM; Shaw EW; Combes B; Fallon HJ; Maddrey WC
    Ann Intern Med; 1989 May; 110(9):685-90. PubMed ID: 2648927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
    Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
    Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.
    Trinchet JC; Beaugrand M; Callard P; Hartmann DJ; Gotheil C; Nusgens BV; Lapiere CM; Ferrier JP
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):551-5. PubMed ID: 2753302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study.
    Bunchorntavakul C; Wootthananont T; Atsawarungruangkit A
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S31-40. PubMed ID: 25509693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
    Mathurin P; Mendenhall CL; Carithers RL; Ramond MJ; Maddrey WC; Garstide P; Rueff B; Naveau S; Chaput JC; Poynard T
    J Hepatol; 2002 Apr; 36(4):480-7. PubMed ID: 11943418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis.
    Hill DB; Barve S; Joshi-Barve S; McClain C
    J Lab Clin Med; 2000 May; 135(5):387-95. PubMed ID: 10811053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.
    Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF
    Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
    Akriviadis E; Botla R; Briggs W; Han S; Reynolds T; Shakil O
    Gastroenterology; 2000 Dec; 119(6):1637-48. PubMed ID: 11113085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis.
    Castera L; Hartmann DJ; Chapel F; Guettier C; Mall F; Lons T; Richardet JP; Grimbert S; Morassi O; Beaugrand M; Trinchet JC
    J Hepatol; 2000 Mar; 32(3):412-8. PubMed ID: 10735610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of
    Sowjanya K; Girish C; Bammigatti C; Prasanna Lakshmi NC
    Indian J Pharmacol; 2021; 53(6):448-456. PubMed ID: 34975132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term vitamin E supplementation in alcoholic cirrhotics.
    de la Maza MP; Petermann M; Bunout D; Hirsch S
    J Am Coll Nutr; 1995 Apr; 14(2):192-6. PubMed ID: 7790695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
    Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.
    Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G
    Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.
    Orrego H; Kalant H; Israel Y; Blake J; Medline A; Rankin JG; Armstrong A; Kapur B
    Gastroenterology; 1979 Jan; 76(1):105-15. PubMed ID: 758131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.